King Yuan Correlations
2449 Stock | TWD 125.50 2.50 1.95% |
The current 90-days correlation between King Yuan Electronics and Powertech Technology is 0.43 (i.e., Very weak diversification). The correlation of King Yuan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
King Yuan Correlation With Market
Modest diversification
The correlation between King Yuan Electronics and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding King Yuan Electronics and DJI in the same portfolio, assuming nothing else is changed.
King |
The ability to find closely correlated positions to King Yuan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace King Yuan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back King Yuan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling King Yuan Electronics to buy it.
Moving together with King Stock
0.8 | 0057 | Fubon MSCI Taiwan | PairCorr |
0.82 | 0050 | YuantaP shares Taiwan | PairCorr |
0.81 | 0053 | YuantaP shares Taiwan | PairCorr |
Moving against King Stock
0.69 | 5514 | Sunfon Construction | PairCorr |
0.62 | 6620 | Handa Pharmaceuticals | PairCorr |
0.59 | 4174 | OBI Pharma | PairCorr |
0.59 | 4192 | SynCore Biotechnology | PairCorr |
0.52 | 6461 | Intech Biopharm | PairCorr |
0.5 | 6541 | Tanvex BioPharma | PairCorr |
0.48 | 6186 | Shin Ruenn Development Split | PairCorr |
0.45 | 4157 | Taigen Biopharmaceutica | PairCorr |
Related Correlations Analysis
0.89 | 0.71 | 0.92 | 0.43 | 6239 | ||
0.89 | 0.73 | 0.91 | 0.47 | 3034 | ||
0.71 | 0.73 | 0.76 | 0.42 | 2441 | ||
0.92 | 0.91 | 0.76 | 0.54 | 2408 | ||
0.43 | 0.47 | 0.42 | 0.54 | 2379 | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between King Stock performing well and King Yuan Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze King Yuan's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
6239 | 1.27 | (0.25) | 0.00 | (0.34) | 0.00 | 2.02 | 7.94 | |||
3034 | 1.13 | (0.21) | 0.00 | (0.49) | 0.00 | 1.97 | 8.21 | |||
2441 | 0.74 | (0.10) | 0.00 | (0.23) | 0.00 | 1.59 | 5.03 | |||
2408 | 1.55 | (0.66) | 0.00 | (1.49) | 0.00 | 3.06 | 7.57 | |||
2379 | 1.34 | (0.20) | 0.00 | (0.51) | 0.00 | 2.37 | 10.68 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in King Yuan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
King Yuan Corporate Management
Elected by the shareholders, the King Yuan's board of directors comprises two types of representatives: King Yuan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of King. The board's role is to monitor King Yuan's management team and ensure that shareholders' interests are well served. King Yuan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, King Yuan's outside directors are responsible for providing unbiased perspectives on the board's policies.
HsinHui Han | VP | Profile | |
AnHsuan Liu | Ex Pres | Profile | |
ChingYao Chao | VP CFO | Profile | |
Gao Chang | Ex VP | Profile | |
ChinKung Lee | Chairman Founder | Profile | |
KunKuang Lee | VP | Profile | |
Neil Chung | Sec Officer | Profile |